4//SEC Filing
WALTON ALAN G 4
Accession 0001140484-05-000010
CIK 0001070494other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 1:43 PM ET
Size
18.5 KB
Accession
0001140484-05-000010
Insider Transaction Report
Form 4
OXFORD BIOSCIENCE PARTNERS IV LP
10% Owner
Transactions
- Purchase
Common Stock Warrant (right to buy)
2005-04-20+146,600→ 146,600 totalExercise: $8.15From: 2005-10-17Exp: 2010-04-19→ Common Stock (146,600 underlying) - Purchase
Common Stock
2005-04-20$6.82/sh+586,402$4,000,024→ 3,160,238 total
Footnotes (1)
- [F1]Securities held of record by Oxford Bioscience Partners IV L.P. ("Oxford IV"). OBP Management IV L.P. ("OBP IV") (as the general partner of Oxford IV), may also be deemed to own beneficially the shares held of record by Oxford IV. Each of Messrs. Barnes, Carthy, Fleming, Lytton, and Walton (who is a Director of the Issuer), the individual general partners of OBP IV, may be deemed to own beneficially the shares held by Oxford IV.
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001214273
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 1:43 PM ET
- Size
- 18.5 KB